Oui, vivre dans des zones où des infections virales sont fréquentes augmente le risque.
EnvironnementInfections viralesRisque
#5
Les voyages à l'étranger augmentent-ils le risque ?
Oui, voyager dans des régions où des épidémies d'infections virales sont présentes peut augmenter le risque.
VoyagesÉpidémiesRisque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Syndrome uvéo-méningo-encéphalique : Questions médicales les plus fréquentes",
"headline": "Syndrome uvéo-méningo-encéphalique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Syndrome uvéo-méningo-encéphalique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-18",
"dateModified": "2025-03-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Syndrome uvéo-méningo-encéphalique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies auto-immunes du système nerveux",
"url": "https://questionsmedicales.fr/mesh/D020274",
"about": {
"@type": "MedicalCondition",
"name": "Maladies auto-immunes du système nerveux",
"code": {
"@type": "MedicalCode",
"code": "D020274",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.111.258"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Syndrome uvéo-méningo-encéphalique",
"alternateName": "Uveomeningoencephalitic Syndrome",
"code": {
"@type": "MedicalCode",
"code": "D014607",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Leen Alblaihed",
"url": "https://questionsmedicales.fr/author/Leen%20Alblaihed",
"affiliation": {
"@type": "Organization",
"name": "Department of Emergency Medicine, University of Maryland School of Medicine, 110 South Paca Street, 6th Floor, Suite 200, Baltimore, MD 21201, USA. Electronic address: https://twitter.com/LeenAlblaihed."
}
},
{
"@type": "Person",
"name": "Maite Anna Huis In 't Veld",
"url": "https://questionsmedicales.fr/author/Maite%20Anna%20Huis%20In%20%27t%20Veld",
"affiliation": {
"@type": "Organization",
"name": "Department of Emergency Medicine, Elisabeth TweeSteden Ziekenhuis, Hilvarenbeekseweg 60, 5022 GC Tilburg, the Netherlands; Department of Emergency Medicine, University of Maryland School of Medicine, MD, USA. Electronic address: m.huisintveld@etz.nl."
}
},
{
"@type": "Person",
"name": "Yehuda Shoenfeld",
"url": "https://questionsmedicales.fr/author/Yehuda%20Shoenfeld",
"affiliation": {
"@type": "Organization",
"name": "Zabludowicz Center for Autoimmune Diseases, Chaim Sheba Medical Center, Tel-Hashomer 5265601, Ramat-Gan; Reichmann University, Herzliya, Israel."
}
},
{
"@type": "Person",
"name": "Rosanna Fulchiero",
"url": "https://questionsmedicales.fr/author/Rosanna%20Fulchiero",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, Inova Children's Hospital, 3300 Gallows Road, Falls Church, VA 22042, USA."
}
},
{
"@type": "Person",
"name": "Patricia Seo-Mayer",
"url": "https://questionsmedicales.fr/author/Patricia%20Seo-Mayer",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, Inova Children's Hospital, 3300 Gallows Road, Falls Church, VA 22042, USA; Division of Nephrology and Hypertension, Pediatric Specialists of Virginia, 3023 Hamaker Court, Suite 600, Fairfax, VA 22031, USA; Virginia Commonwealth School of Medicine, Richmond, VA, USA. Electronic address: Pseo-mayer@psvcare.org."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Performance of VisuALL virtual reality visual field testing in healthy children.",
"datePublished": "2024-01-14",
"url": "https://questionsmedicales.fr/article/38219921",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jaapos.2023.10.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison of the visual field test of Glaufield Lite with Humphrey Field Analyser.",
"datePublished": "2022-08-10",
"url": "https://questionsmedicales.fr/article/35947251",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10792-022-02457-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Impact of peripapillary retinoschisis on visual field test results in glaucomatous eyes.",
"datePublished": "2022-06-21",
"url": "https://questionsmedicales.fr/article/35728936",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bjophthalmol-2021-320509"
}
},
{
"@type": "ScholarlyArticle",
"name": "Predicting 60-4 visual field tests using 3D facial reconstruction.",
"datePublished": "2023-12-18",
"url": "https://questionsmedicales.fr/article/36428007",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bjo-2022-321651"
}
},
{
"@type": "ScholarlyArticle",
"name": "A new static visual field test algorithm: the Ambient Interactive ZEST (AIZE).",
"datePublished": "2023-09-11",
"url": "https://questionsmedicales.fr/article/37696993",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-42266-z"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies auto-immunes",
"item": "https://questionsmedicales.fr/mesh/D001327"
},
{
"@type": "ListItem",
"position": 4,
"name": "Maladies auto-immunes du système nerveux",
"item": "https://questionsmedicales.fr/mesh/D020274"
},
{
"@type": "ListItem",
"position": 5,
"name": "Syndrome uvéo-méningo-encéphalique",
"item": "https://questionsmedicales.fr/mesh/D014607"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Syndrome uvéo-méningo-encéphalique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Syndrome uvéo-méningo-encéphalique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Syndrome uvéo-méningo-encéphalique",
"description": "Comment diagnostiquer le syndrome uvéo-méningo-encéphalique ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels signes cliniques indiquent ce syndrome ?\nLe syndrome peut-il être confondu avec d'autres maladies ?\nQuelle est l'importance de l'analyse du LCR ?",
"url": "https://questionsmedicales.fr/mesh/D014607?mesh_terms=Visual+Field+Tests#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Syndrome uvéo-méningo-encéphalique",
"description": "Quels sont les symptômes principaux du syndrome ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes varient-ils selon l'âge ?\nPeut-on avoir de la fièvre avec ce syndrome ?\nLes symptômes sont-ils toujours présents ?",
"url": "https://questionsmedicales.fr/mesh/D014607?mesh_terms=Visual+Field+Tests#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Syndrome uvéo-méningo-encéphalique",
"description": "Comment prévenir le syndrome uvéo-méningo-encéphalique ?\nLes vaccinations sont-elles efficaces ?\nQuelles mesures d'hygiène sont recommandées ?\nY a-t-il des groupes à risque ?\nLes voyages augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014607?mesh_terms=Visual+Field+Tests#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Syndrome uvéo-méningo-encéphalique",
"description": "Quel est le traitement principal du syndrome ?\nLes antibiotiques sont-ils nécessaires ?\nComment gérer les symptômes neurologiques ?\nY a-t-il des traitements préventifs ?\nQuelle est la durée du traitement ?",
"url": "https://questionsmedicales.fr/mesh/D014607?mesh_terms=Visual+Field+Tests#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Syndrome uvéo-méningo-encéphalique",
"description": "Quelles sont les complications possibles ?\nLe syndrome peut-il entraîner des séquelles à long terme ?\nY a-t-il un risque de récidive ?\nComment surveiller les complications ?\nLes complications peuvent-elles être évitées ?",
"url": "https://questionsmedicales.fr/mesh/D014607?mesh_terms=Visual+Field+Tests#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Syndrome uvéo-méningo-encéphalique",
"description": "Quels sont les facteurs de risque connus ?\nL'âge influence-t-il le risque ?\nLes antécédents médicaux jouent-ils un rôle ?\nL'environnement peut-il affecter le risque ?\nLes voyages à l'étranger augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014607?mesh_terms=Visual+Field+Tests#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer le syndrome uvéo-méningo-encéphalique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique, l'imagerie cérébrale et des analyses de liquide céphalorachidien."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des IRM, des tomodensitométries et des analyses de sang et de LCR sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent ce syndrome ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des maux de tête, des troubles visuels et des convulsions peuvent indiquer le syndrome."
}
},
{
"@type": "Question",
"name": "Le syndrome peut-il être confondu avec d'autres maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être confondu avec d'autres infections neurologiques comme la méningite bactérienne."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'analyse du LCR ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'analyse du LCR permet de détecter des signes d'inflammation et d'infection, cruciaux pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux du syndrome ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maux de tête, des troubles de la vision, et des signes neurologiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des convulsions, des troubles de la conscience et des déficits neurologiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'âge et de la gravité de l'infection."
}
},
{
"@type": "Question",
"name": "Peut-on avoir de la fièvre avec ce syndrome ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fièvre est un symptôme fréquent, souvent accompagnée de signes d'inflammation."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours présents ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certains patients peuvent présenter des symptômes légers ou intermittents."
}
},
{
"@type": "Question",
"name": "Comment prévenir le syndrome uvéo-méningo-encéphalique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par la vaccination contre les infections virales et l'hygiène personnelle."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations peuvent réduire le risque d'infections virales associées au syndrome."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains régulièrement et éviter le contact avec des personnes malades sont recommandés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des groupes à risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes immunodéprimées et celles vivant dans des zones d'épidémie sont à risque accru."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones où des infections virales sont endémiques peut augmenter le risque."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal du syndrome ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal inclut des antiviraux, des corticostéroïdes et des soins de soutien."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils nécessaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques ne sont pas efficaces contre les infections virales, mais peuvent être utilisés si une infection bactérienne est suspectée."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes neurologiques ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes neurologiques peuvent être gérés par des anticonvulsivants et des soins neurologiques spécialisés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements préventifs ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de traitements préventifs spécifiques pour ce syndrome."
}
},
{
"@type": "Question",
"name": "Quelle est la durée du traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée du traitement varie selon la gravité de l'infection et la réponse au traitement, souvent plusieurs semaines."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des séquelles neurologiques, des troubles de la vision et des crises épileptiques."
}
},
{
"@type": "Question",
"name": "Le syndrome peut-il entraîner des séquelles à long terme ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent développer des séquelles neurologiques à long terme après le traitement."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de récidive ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le risque de récidive dépend de la cause sous-jacente et de l'état immunitaire du patient."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier avec des examens neurologiques et des imageries est essentiel pour surveiller les complications."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être évitées ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être évitées par un traitement précoce et approprié de l'infection."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque connus ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'immunodépression, les infections virales antérieures et l'exposition à des vecteurs."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées sont souvent plus à risque de développer ce syndrome."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents d'infections neurologiques augmentent le risque de développer ce syndrome."
}
},
{
"@type": "Question",
"name": "L'environnement peut-il affecter le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, vivre dans des zones où des infections virales sont fréquentes augmente le risque."
}
},
{
"@type": "Question",
"name": "Les voyages à l'étranger augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des régions où des épidémies d'infections virales sont présentes peut augmenter le risque."
}
}
]
}
]
}
Department of Emergency Medicine, University of Maryland School of Medicine, 110 South Paca Street, 6th Floor, Suite 200, Baltimore, MD 21201, USA. Electronic address: https://twitter.com/LeenAlblaihed.
Publications dans "Syndrome uvéo-méningo-encéphalique" :
Department of Emergency Medicine, Elisabeth TweeSteden Ziekenhuis, Hilvarenbeekseweg 60, 5022 GC Tilburg, the Netherlands; Department of Emergency Medicine, University of Maryland School of Medicine, MD, USA. Electronic address: m.huisintveld@etz.nl.
Publications dans "Syndrome uvéo-méningo-encéphalique" :
Department of Pediatrics, Inova Children's Hospital, 3300 Gallows Road, Falls Church, VA 22042, USA; Division of Nephrology and Hypertension, Pediatric Specialists of Virginia, 3023 Hamaker Court, Suite 600, Fairfax, VA 22031, USA; Virginia Commonwealth School of Medicine, Richmond, VA, USA. Electronic address: Pseo-mayer@psvcare.org.
Publications dans "Syndrome uvéo-méningo-encéphalique" :
Virtual reality field testing may provide an alternative to standard automated perimetry. This study evaluates a virtual reality game-based automated perimetry in a healthy pediatric population....
A prospective series of pediatric patients at one institution who performed VisuALL perimetry (Olleyes Inc, Summit, NJ) using a game-based algorithm. Participants were examined by an experienced pedia...
A total of 191 eyes of 97 patients (54% female) were included, with a mean age of 11.9 ± 3.1 years. The average MD was -1.82 ± 3.5 dB, with a mean foveal sensitivity of 32.0 ± 4.7 dB. Fifty-nine eyes ...
VisuALL virtual reality field testing was well tolerated in this pediatric study cohort. Older age and shorter test duration were associated with better performance on field testing....
To compare visual field test results of Glaufield Lite AP901 CTS 133 (Appasamy Associates, Mannadipet Commune, Thirubhuvanai, Puducherry, India, hereafter Glaufield Lite) with Humphrey Field Analyser ...
A pilot study at a tertiary eye centre involving 23 normal and 24 glaucoma patients who underwent two consecutive visual field tests on (i) HFA 24-2 SITA Fast and (ii) Glaufield Lite Quick Central pro...
The mean testing time on HFA was significantly shorter than Glaufield Lite (normals: HFA: 2.75 ± 0.49 min, Glaufield Lite: 6.85 ± 0.86 min, p < 0.001; glaucoma patients: HFA: 3.45 ± 1.08 min, Glaufiel...
Both perimetric techniques showed reliable test results though test duration was longer with Glaufield Lite perimetry. The MD showed poor agreement, likely due to different scales and principles used ...
To investigate the influence of peripapillary retinoschisis (PRS) on visual field (VF) test results in patients with primary open angle glaucoma (POAG)....
Thirty eyes of 30 patients with POAG who had PRS at least once were included. All eyes were followed-up for a minimum 5 years at 4-6-month intervals. The occurrence of PRS was determined by circumpapi...
Global MD (p=0.345) and regional VF deviations (p=0.255) did not differ significantly between immediately after and just prior to PRS formation. Global MD (p=0.846) and regional VF deviations (p=0.758...
PRS has no short-term effect on the VF sensitivity. Therefore, VF test can still be useful for evaluating glaucomatous damage even in the presence of PRS compared with OCT....
Despite, the potential clinical utility of 60-4 visual fields, they are not frequently used in clinical practice partly, due to the purported impact of facial contour on field defects. The purpose of ...
Subjects with no ocular pathology were included. Participants were subject to optical coherence tomography, 60-4 Swedish interactive thresholding algorithm visual field tests and photography. The pred...
30 healthy were enrolled. Three-dimensional facial reconstruction using a convolution neural network (CNN) was able to predict facial contour-dependent 60-4 visual field defects in 30 subjects without...
This pilot study reports the development of a CNN-enhanced platform capable of predicting 60-4 visual field defects in healthy controls based on facial contour. Further study with this platform may en...
Visual field (VF) test is one of the most vital tests in the diagnosis of glaucoma and to monitor the disease worsening. In the past couple of decades, the standard automated perimetry (SAP) test take...
To compare clinical visual field outputs in glaucoma and healthy patients returned by the Humphrey Field Analyzer (HFA) and virtual reality (Virtual Field, VF) perimetry....
One eye of 54 glaucoma patients and 41 healthy subjects was prospectively tested (three times each in random order) using the HFA and VF perimeters (24-2 test grids). We extracted and compared global ...
The VF test was shorter (by 76 s) and had lower fixation losses (by 0.08) and false-positive rate (by 0.01) compared to the HFA (all p < 0.0001). Intraclass correlations were 0.86, 0.82 and 0.47 for M...
Virtual Field returns global results that are correlated with the HFA, but pointwise sensitivities were more variable. Differences in test-retest variability and defect detection by its current normat...
We evaluated 16,351 visual field (VF) tests from Ocular Hypertension Treatment Study (OHTS) database and showed that more frequent testing resulted in a shorter time to detect glaucoma progression, wi...
To investigate the effect of different testing intervals on time to detect visual field progression in eyes with ocular hypertension....
A total of 16,351 reliable 30-2 VF tests from 1575 eyes of the OHTS-1 observation arm with a mean (95% CI) follow-up of 4.8 (4.7-4.8) years were analyzed. Computer simulations (n = 10,000 eyes) based ...
At 80% power, based on the progression of -0.42 dB/year, the best trade-off to detect significant rates of VF change to clinically meaningful perimetric loss in high, medium, and low-risk patients was...
Given the importance of not missing the conversion to glaucoma, the frequency of testing used in OHTS (6 mo) was optimal for the detection of progression in high-risk patients. Low-risk patients could...
This study of inter-test comparability of a novel visual field application installed on an augmented-reality portable headset and Humphrey field analyzer Swedish interactive thresholding algorithm (SI...
To determine the correlation between visual field testing with novel software on a wearable headset versus standard automated perimetry....
Patients with and without visual field defects attributable to glaucoma had visual field testing in one eye of each patient with 2 methods: re:Imagine Strategy (Heru, Inc.) and the Humphrey field anal...
Measurements from 89 eyes of 89 patients (18 normal and 71 glaucomas) were compared with both instruments. Linear regression analysis demonstrated an excellent Pearson correlation coefficient of r = 0...
The Heru visual field test correlated well with SITA Standard in a population of normal eyes and eyes with glaucoma....
The aim of the study is to analyze visual fields defects (VFDs) in epidemic retinitis (ER)....
Patients with ER and Humphrey's visual field (HFA) 30-2 performed after resolution were studied. VFD severity grading was performed. Patients treated with oral doxycycline (Group-A) versus doxycycline...
Thirty-five eyes of 25 patients were studied. Nasal, inferior, temporal and central VFD were seen in 19 (54.2%), 13 (37.1%), 7 (20%) and 6 (17.1%) eyes, respectively. Grade 0, 1, 2 and 3 VFDs were see...
ER can cause VFD persisting long after resolution. Treatment with oral doxycycline without steroids was non-inferior to combined treatment with respect to VFD....
To compare the ability of imo binocular random single-eye test (BRSET) to detect visual field (VF) defects due to chiasmal and postchiasmal lesions (C/PCLs) with a Humphrey Field Analyzer (HFA) monocu...
Prospective multicenter study METHODS: This study enrolled 40 patients with C/PCLs and measured their VFs using both imo BRSET and HFA monocular test. The VFs were classified into three groups using t...
The VFs of 34 patients were analyzed and classified. There were 13 patients in the bitemporal, 6 in the homonymous, and 15 in the others group. BRSET showed a significantly shorter test duration than ...
BRSET detected VF defects due to C/PCLs as accurately as the HFA monocular test with a shorter test duration....